Published in Adv Exp Med Biol on January 01, 1976
Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics (1990) 3.53
Side effects of long-term amiodarone therapy. Circulation (1983) 3.03
Echocardiographic measurement of the normal adult right ventricle. Br Heart J (1986) 2.16
Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study. Br Heart J (1979) 2.06
Chronic social stress, social status, and susceptibility to upper respiratory infections in nonhuman primates. Psychosom Med (1997) 1.92
Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. Br Heart J (1980) 1.64
In vitro studies on the mechanism of macrophage migration inhibition in tuberculin sensitivity. J Immunol (1968) 1.55
Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol. Br Heart J (1983) 1.52
Catheter ablation for successful management of left posterior fascicular tachycardia: an approach guided by recording of fascicular potentials. Heart (1996) 1.47
HLA-A1 and coalworkers' pneumoconiosis. Am Rev Respir Dis (1979) 1.44
Ventricular tachycardia of left bundle branch block configuration in patients with isolated right ventricular dilatation. Clinical and electrophysiological features. Br Heart J (1984) 1.42
Clinical anatomy of the atrioventricular junctions. J Am Coll Cardiol (1994) 1.41
Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. Br Heart J (1989) 1.40
Side effects and possible contraindications of amiodarone use. Am Heart J (1983) 1.40
The Prevalence of Rabies in the United States and the World. Am J Public Health Nations Health (1928) 1.39
HLA standardization and proficiency testing in the Southeastern organ Procurement Foundation. Transplantation (1982) 1.38
Successful radiofrequency ablation of accessory pathways with the first energy delivery: the anatomic and electrical characteristics. Eur Heart J (1996) 1.38
Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest (1995) 1.37
Rapid and safe termination of supraventricular tachycardia in children by adenosine. Lancet (1987) 1.35
Amiodarone therapy during pregnancy. Am J Cardiol (1983) 1.35
Factors in delayed sensitivity: lymphocyte and macrophage cytotoxins in the tuberculin reaction. J Immunol (1969) 1.32
Treatment of refractory supraventricular arrhythmias with flecainide acetate. Arch Dis Child (1987) 1.28
Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol (1984) 1.26
Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol (1995) 1.26
The relationship between posture, blood pressure and electrophysiological properties in patients with paroxysmal supraventricular tachycardia. Arch Mal Coeur Vaiss (1978) 1.25
Low energy catheter ablation of a posteroseptal accessory pathway associated with a diverticulum of the coronary sinus. Pacing Clin Electrophysiol (1991) 1.23
Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J (1980) 1.20
Endocardial pacing in infants and children 15 kg or less in weight: medium-term follow-up. Pacing Clin Electrophysiol (1990) 1.13
Electrophysiological manifestations of non-penetrating cardiac trauma. Br Heart J (1980) 1.12
Concealed pre-excitation. J Electrocardiol (1978) 1.11
Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1999) 1.11
Radiofrequency catheter ablation of Mahaim tachycardia by targeting Mahaim potentials at the tricuspid annulus. Br Heart J (1995) 1.10
Localization of accessory pathways from the 12-lead electrocardiogram using a new algorithm. Am J Cardiol (1994) 1.09
Alcohol catheter ablation of atrioventricular conduction. Br Heart J (1991) 1.07
Amiodarone: the experience of the past decade. Br Med J (Clin Res Ed) (1983) 1.04
Coronary venous aneurysms and accessory atrioventricular connections. Br Heart J (1988) 1.00
Role of calcium antagonists in cardiovascular therapy. Br Heart J (1981) 0.98
Dispersion of monophasic action potential duration: demonstrable in humans after premature ventricular extrastimulation but not in steady state. J Am Coll Cardiol (1992) 0.97
Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents. Eur Heart J (2002) 0.96
HLA-B8 in sarcoidosis. Ann Allergy (1981) 0.94
Circadian variation of malignant ventricular arrhythmias in patients with ischemic and nonischemic heart disease after cardioverter defibrillator implantation. European 7219 Jewel Investigators. J Am Coll Cardiol (1999) 0.93
Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutter. Heart (2001) 0.92
A new low energy power source for catheter ablation. Pacing Clin Electrophysiol (1986) 0.92
Tuberculin sensitivity: the effect of antilymphocyte and antimacrophage serum on cutaneous, systemic and in vitro reactions. J Immunol (1970) 0.91
A study of pyramidal cell axon collaterals in intact and partially isolated adult cerebral cortex. Brain Res (1969) 0.91
Right ventricular abnormalities in ventricular tachycardia of right ventricular origin: relation to electrophysiological abnormalities. Br Heart J (1986) 0.91
Histopathological findings in three children with His bundle tachycardia occurring subsequent to cardiac surgery. Eur Heart J (1992) 0.90
Prediction of atrioventricular block during radiofrequency ablation of the slow pathway of the atrioventricular node. Circulation (1995) 0.90
HLA-DQ matching in cadaveric renal transplantation. Clin Transplant (1997) 0.89
Catheter ablation without fulguration: design and performance of a new system. Pacing Clin Electrophysiol (1989) 0.89
Low-energy ablation of accessory pathways in cases for which the radiofrequency approach had failed. Am J Cardiol (1993) 0.89
The plasma atrial natriuretic peptide response to treatment of acute cardiac failure, spontaneous supraventricular tachycardia and induced re-entrant tachycardia in man. J Hypertens Suppl (1986) 0.88
Low energy catheter ablation of right ventricular outflow tract tachycardia. Br Heart J (1991) 0.88
Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks. Heart (1996) 0.88
Primary ventricular fibrillation is associated with increased paced right ventricular electrogram fractionation. Circulation (1995) 0.88
Atrial pacing as an adjunct to the management of post-surgical His bundle tachycardia. Br Heart J (1991) 0.87
Local abnormalities of right ventricular depolarization after repair of tetralogy of Fallot: a basis for ventricular arrhythmia. Am J Cardiol (1985) 0.86
Effect of multisite pacing on ventricular coordination. Heart (2002) 0.86
Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris. Am Heart J (1982) 0.86
Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms. Eur Heart J (1995) 0.86
Testicular germ cell tumors in HLA-genotype non-twin brothers. Urology (1988) 0.86
Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia. Am J Cardiol (1985) 0.86
The Wolff-Parkinson-White syndrome: the cellular substrate for conduction in the accessory atrioventricular pathway. Eur Heart J (1994) 0.85
Dual-demand pacing for refractory atrioventricular re-entry tachycardia. Pacing Clin Electrophysiol (1979) 0.85
Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation. Eur Heart J (1997) 0.85
HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis. Am J Kidney Dis (1994) 0.84
Long-term follow up of patients treated with a software based antitachycardia pacemaker. Br Heart J (1993) 0.84
Effects of intravenous adenosine on verapamil-sensitive "idiopathic" ventricular tachycardia. Am J Cardiol (1994) 0.83
Impedance changes during catheter ablation and their relationship to electrical arcing and clinical efficacy. Pacing Clin Electrophysiol (1989) 0.83
Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients. Cancer Res (1979) 0.83
Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics. Br Heart J (1989) 0.83
Temporal arteritis in Sjögren's syndrome. Clin Exp Rheumatol (1986) 0.82
Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium. Heart (2001) 0.82
Intracardiac contrast echoes during transvenous His bundle ablation. Br Heart J (1985) 0.82
Comparison between biventricular pacing and single site pacing in patients with poor ventricular function: a hemodynamic study. Pacing Clin Electrophysiol (2003) 0.82
Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol (1988) 0.82
Conservation of the HLA-DQB2 locus in nonhuman primates. J Immunol (1992) 0.81
Relation between atrioventricular pathways and ventricular response during atrial fibrillation and flutter. Br Heart J (1981) 0.81
HLA associations in end-stage renal disease due to membranous glomerulonephritis: HLA-DR3 associations with progressive renal injury. Southeastern Organ Procurement Foundation. Am J Kidney Dis (1994) 0.81
Induction of delayed-type sensitivity-like reactions in the eye by the injection of lymphokines. Invest Ophthalmol (1973) 0.81
Myocardial injury induced by radiofrequency and low energy ablation: a quantitative study of CK isoforms, CK-MB, and troponin-T concentrations. Pacing Clin Electrophysiol (1998) 0.81
Electrical restitution in the endocardium of the intact human right ventricle. Br Heart J (1992) 0.81
Conservation of the promoter region of DRA-like genes from nonhuman primates. Immunogenetics (1992) 0.80
Conservation of HLA class I private epitopes in macaques. Immunogenetics (1988) 0.80
Racial differences in HLA antigen frequency and hypertensive renal failure. Am J Hypertens (1991) 0.80
Clinical competence in electrophysiological techniques. Heart (1997) 0.80
Assessment of a prototype implantable cardioverter for ventricular tachycardia. Relation between synchronisation of sensing and origin of the tachycardia. Br Heart J (1984) 0.80
Maze 3 for atrial fibrillation: two cuts too few? Pacing Clin Electrophysiol (1994) 0.80
The tricuspid valve: an unusual site of endocardial pacemaker lead fracture. Pacing Clin Electrophysiol (1989) 0.80
Radiofrequency catheter ablation of accessory atrioventricular pathways: primary failure and recurrence of conduction. Heart (1997) 0.80
Is vagal innervation to the atrioventricular node impaired after radiofrequency ablation of the slow atrioventricular nodal pathway? Pacing Clin Electrophysiol (1996) 0.79
Wolff-Parkinson-White syndrome: atrial fibrillation as the presenting arrhythmia. Br Heart J (1988) 0.79
Delayed hypersensitivity to hapten-skin protein conjugates in guinea pigs sensitized to benzo(a)pyrene. Int Arch Allergy Appl Immunol (1978) 0.79
Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function. Am J Cardiol (1985) 0.79
Biochemical analysis of class I and class II MHC antigens in cynomolgus macaques by one-dimensional isoelectric focusing. Tissue Antigens (1991) 0.79
Migration inhibition response of mononuclear cells mediating granulomatous inflammation. Ser Haematol (1970) 0.79
Relationship of the effective refractory period and monophasic action potential duration after a step increase in pacing frequency. Pacing Clin Electrophysiol (1990) 0.78
Conservation of the HLA-DQB2 locus in nonhuman primates. J Immunol (1992) 0.78
A race-controlled human leukocyte antigen frequency analysis in lupus nephritis. The South-Eastern Organ Procurement Foundation. Am J Kidney Dis (1993) 0.78
Amiodarone for the conversion of established atrial fibrillation and flutter. Br J Clin Pract Suppl (1986) 0.78